Stocks to buy today: 9 short-term trading ideas by experts for 18 December, 2023

Stocks to buy today: 9 short-term trading ideas by experts for 18 December, 2023

Indian headline indices hit fresh lifetime highs on Friday ending with weekly gains of 2.7% on a dovish pivot by the US Fed. The biggest gainers were IT and bank stocks. Nifty hit a new lifetime high of 21,492.30 before ending the session at 21,456.65, up 273.95 points or 1.29%. The 30-stock S&P BSE Sensex … Read more

Radhakishan Damani, Hemendra Kothari among India’s top stock market investors

Radhakishan Damani, Hemendra Kothari among India’s top stock market investors

TAQA Looks to Bet Big on Adani’s Power Biz Abu Dhabi National Energy Co. PJSC (TAQA) is looking to double down on India and is evaluating a large exposure in the expansive power businesses of Gautam Adani that span thermal generation to transmission, clean energy and green hydrogen, said people aware of the matter. Big … Read more

Stocks to buy today: Tata Motors, SBI among top 6 trading ideas for 10 July 2023

Stocks to buy today: Tata Motors, SBI among top 6 trading ideas for 10 July 2023

Indian market is likely to consolidate on Monday tracking mixed global cues. The S&P BSE Sensex fell more than 500 points while the Nifty50 closed below 19400 levels on Friday. India VIX was down by 2.60% from 11.84 to 11.53 levels on Friday. Volatility sunk lower and is hovering near its lower band which may … Read more

Big Movers on D-St: What should investors do with Raymond, Glenmark Pharma and KPIT Technologies?

Big Movers on D-St: What should investors do with Raymond, Glenmark Pharma and KPIT Technologies?

Indian market closed in the green for the sixth day in a row on Thursday following positive global cues. The S&P BSE Sensex rose more than 300 points while Nifty50 closed above 17900 levels. Sectorally, buying was seen in realty, telecom, IT, auto, and metals while selling was visible in power, and infra stocks. Stocks … Read more

Can PLI, China Plus One keep India’s pharma sector in pink of health?

Can PLI, China Plus One keep India’s pharma sector in pink of health?

The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more